High expression of JAM2 indicates better prognosis and immunotherapy response in breast cancer
Yang Peng(Liaocheng University), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Chi Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yingzi Zhang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jian Xie(Zunyi Medical University), Bin Jian(Chongqing Medical University), Yong Fu(Shanghai Jiao Tong University), Beige Zong(First Affiliated Hospital of Chongqing Medical University)
Cited by 1
Related Papers
Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
|The International Journal of Neuropsychopharmacology|2011|430
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
Diagnostic Value of Circulating Chromogranin A for Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
|PLoS ONE|2015|101
CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis
|International Journal of Oncology|2019|77